Community Health Systems Inc.

Community Health Systems is a holding company. Through its subsidiaries, the company operates general acute care hospitals and outpatient facilities. The company provides healthcare services through the hospitals that it owns and operates and affiliated businesses in non-urban and selected urban markets. Services provided through the company's hospitals and affiliated businesses include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. The company also provides additional outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers.
  • TickerCYH
  • ISINUS2036681086
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States
Valens Research

Valens Credit Weekly Insights - 2021 01 13

Valens Credit Research Team highlighted ideas for CAR, GHC, and WH. They have also provided recent analyses for GT, while RIG topped the quantitative outlier report for the week.

Valens Research

Valens Credit Weekly Insights - 2020 12 30

Valens Credit Research Team highlighted ideas for GM, MTOR, and TWTR. They have also provided recent analysis for ENR, while RIG topped the quantitative outlier report for the week.

Valens Research

Valens Credit Weekly Insights - 2020 12 23

Valens Credit Research Team highlighted ideas for MAR, MDP, and SKT. They have also provided recent analyses for RIG and VSAT, while RIG topped the quantitative outlier report for the week.

Valens Research

Valens Equity Insights and Inflections - 2020 12 22

CBRL has been steadily improving UAFRS-based (Uniform) ROA the past 10 years, thanks to its strong strategy to optimize its restaurant and store business. While the market is pricing the company for returns post-pandemic to decline to multi-year lows absent 2020,the company's strategy primes them for ROA expansion. The company's resiliency through the pandemic, combined with its ability to accelerate growth with its decision to roll-out alcohol puts it in place to see significant return expansion and growth the market is not recognizing. On top of that, management's compensation aligns them ...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Equities Testing Support Coronavirus concerns are reverberating throughout markets, and there is no way to know for certain how serious things will get -- or how much further markets could sell off as a result. What we can say is our weight of the evidence approach suggests this is a contained pullback for now, and that several areas of the market are testing key support. This suggests the potential for a bounce at current levels. At the same time, in light of steep uptrend breakdowns for extended leadership areas (Nasdaq, S&P 500, Technology, AAPL, large-cap growth) stemming from yesterday's...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of names in the Communications Sector are showing signs of leadership. (ex. GLUU, and CNSL) • Consumer Discretionary continues to have a number of attractive names technically. (ex. TXRH, BLMN, WEN, CBRL, SCI, LL, and STMP) • Healthcare has a number of attractive names technically. (ex. SEM, CYH, THC, PRSC, TRHC, HQY, GILD, EBS, REGN, and ABBV) • REIT's remain a leadership Sector (ex. STAR, HR, SAFE, DLR, SBAC, and EQIX)

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Examining Prior Extended Periods Despite our concerns regarding the growing performance disparity between the haves (e.g., Technology, FAANG, mega-caps, growth) and the have nots (e.g., Materials, Energy, small-caps, value), the silver lining continues to be that the latter group is not breaking down on an absolute (price) basis. Due to this fact along with several observations highlighted below, we remain bullish. Continue to buy the dips. • Sector Relative Strength Rankings & Weighting Recommendations. Cap-weighted growth Sectors Technology, Services, Discretionary, and Communications co...

Community Health Systems Inc: 1 director sold

A director at Community Health Systems Inc sold 30,000 shares at 5.169USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The n...

Valens Research

Valens Credit Weekly Insights - 2021 01 13

Valens Credit Research Team highlighted ideas for CAR, GHC, and WH. They have also provided recent analyses for GT, while RIG topped the quantitative outlier report for the week.

Valens Research

Valens Credit Weekly Insights - 2020 12 30

Valens Credit Research Team highlighted ideas for GM, MTOR, and TWTR. They have also provided recent analysis for ENR, while RIG topped the quantitative outlier report for the week.

Valens Research

Valens Credit Weekly Insights - 2020 12 23

Valens Credit Research Team highlighted ideas for MAR, MDP, and SKT. They have also provided recent analyses for RIG and VSAT, while RIG topped the quantitative outlier report for the week.

Valens Research

Valens Equity Insights and Inflections - 2020 12 22

CBRL has been steadily improving UAFRS-based (Uniform) ROA the past 10 years, thanks to its strong strategy to optimize its restaurant and store business. While the market is pricing the company for returns post-pandemic to decline to multi-year lows absent 2020,the company's strategy primes them for ROA expansion. The company's resiliency through the pandemic, combined with its ability to accelerate growth with its decision to roll-out alcohol puts it in place to see significant return expansion and growth the market is not recognizing. On top of that, management's compensation aligns them ...

Valens Research

Valens Credit Weekly Insights - 2018 05 09

Valens Credit Research Team highlighted ideas for CYH, DOOR, and X. They have also provided recent analyses for AL and GOGO, while CYH topped the quantitative outlier report for the week.

Valens Research

Valens Credit Weekly Insights - 2018 05 02

Valens Credit Research Team highlighted ideas for CAR, DNR, and WU. They have also provided recent analyses for RCL and UVV, while CYH topped the quantitative outlier report for the week.

Valens Research

Valens Credit Weekly Insights - 2018 04 25

Valens Credit Research Team highlighted ideas for BZH, MNI, and YRCW. They have also provided recent analyses for AXL and DF, while CYH topped the quantitative outlier report for the week.

Valens Research

Valens Credit Weekly Insights - 2018 04 18

Valens Credit Research Team highlighted ideas for AN, AVP, and UIS. They have also provided recent analyses for SUM and AMKR, while CYH topped the quantitative outlier report for the week.

Valens Research

Valens Credit Weekly Insights - 2018 04 11

Valens Credit Research Team highlighted ideas for AER, CHK, and NFX. They have also provided recent analyses for ENDP and OC, while CYH topped the quantitative outlier report for the week.

COMMUNITY HEALTH SYSTEMS sees a downgrade to Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of COMMUNITY HEALTH SYSTEMS (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Negative. As of the analysis date October 27, 2020, the closing price was USD 4.39 and its target price was estimated at USD 1.91.

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch